[1]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114-115.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(03):114-115.[doi:10.3969/j.issn.1006-1959.2018.03.038]
点击复制

经股和桡动脉介入治疗冠心病的临床疗效对比()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年03期
页码:
114-115
栏目:
临床研究
出版日期:
2018-02-01

文章信息/Info

Title:
Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery
文章编号:
1006-1959（2018）03-0114-02
作者:
张挺挺
江西省九江市都昌县人民医院心内科，江西 都昌 332600
Author(s):
ZHANG Ting-ting
Department of Cardiology,Duchang People's Hospital,Duchang 332600,Jiangxi,China
关键词:
冠心病; 股动脉; 桡动脉; 介入治疗; 穿刺
Keywords:
Coronary heart disease; Femoral artery; Radial artery; Iinterventional therapy; Puncture
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2018.03.038
文献标志码:
A
摘要:
目的 观察对冠心病患者采用经股动脉和桡动脉两种不同介入途径治疗的临床效果。方法 选择我院2015年1月~2016年12月收治的60例冠心病患者，平均分为对照组（n=30）与观察组（n=30）。对照组患者经股动脉穿刺治疗，观察组患者经桡动脉穿刺治疗，对比两组患者置入支架情况、对比剂用量、手术时间、住院时间、穿刺成功率以及术后并发症情况。结果 对照组与观察组患者置入支架数量、所置入支架的直径、长度、所需对比剂用量以及置管成功率之间差异无统计学意义（P＞0.05）；观察组患者平均手术时间、住院时间及并发症发生率显著优于对照组，差异有统计学意义（P＜0.05）。结论 经桡动脉穿刺介入治疗冠心病临床效果较好，具有手术时间短、住院时间短、术后并发症少的优势，更值得临床应用和推广。
Abstract:
Objective To observe the clinical effect of transfemoral artery and radial artery intervention in patients with coronary heart disease.Methods From January 2015 to December 2016,60 patients with coronary heart disease were selected and divided into control group(n= 30)and the observation group(n=30).The patients in the control group were treated by femoral artery puncture,and the patients in the observation group were treated by radial artery puncture.Stent placement,dosage of contrast agent,operation time,hospital stay,puncture success rate and postoperative complications were compared between the two groups.Results There was no significant difference between the control group and the observation group in the number of stents,the diameter and length of the stents, the amount of contrast agents needed and the success rate of catheterization(P>0.05).The average operation time, hospital stay and complication rate in the observation group were significantly better than those in the control group,the difference was statistically significant(P<0.05).Conclusion Transradial artery puncture interventional therapy for coronary heart disease has the advantages of short operation time,short hospital stay and less postoperative complications,which is worthy of clinical application and popularization.

参考文献/References:

[1]郑志虹,王环宇.经股动脉与经桡动脉介入治疗高龄冠心病对比研究[J].中国实用医药,2014,9(35):145-146.
[2]王共华,任文清.高危冠心病患者经桡动脉及经股动脉介入治疗术的疗效比较[J].航空航天医学杂志,2015,26(10):1218-1219.
[3]郭凤贤.不同动脉穿刺途径冠脉介入术治疗高龄冠心病临床疗效分析[J].湖北民族学院学报(医学版),2016,33(04):69-70,73.
[4]郑彩虹,董惠翔,黄战军,等.经股动脉与经桡动脉径路介入术治疗冠心病的临床效果对比观察[J].临床医学,2016,36(12):27-29.
[5]古拜热木·艾买尔.经股动脉与桡动脉两种路径介入治疗冠心病的安全性与有效性对比分析[J].中西医结合心脑血管病杂志,2014,12(10):1191-1193.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[3]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(03):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[4]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(03):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[5]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(03):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[6]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(03):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[7]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(03):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[8]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(03):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[9]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
　GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Journal of Medical Information,2018,31(03):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[10]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
　WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Journal of Medical Information,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
[11]杜依浓.经桡动脉与股动脉途径介入治疗老年冠心病患者的疗效及安全性比较[J].医学信息,2022,35(12):172.[doi:10.3969/j.issn.1006-1959.2022.12.043]
　DU Yi-nong.Comparison of Efficacy and Safety of Interventional Therapy through Radial Artery and Femoral Artery in Elderly Patients with Coronary Heart Disease[J].Journal of Medical Information,2022,35(03):172.[doi:10.3969/j.issn.1006-1959.2022.12.043]

更新日期/Last Update: 2018-02-01